Cadila Healthcare tumbles on reporting 29% fall in Q2 consolidated net profit

26 Oct 2016 Evaluate

Cadila Healthcare is currently trading at Rs. 381.40, down by 26.30 points or 6.45% from its previous closing of Rs. 407.70 on the BSE.

The scrip opened at Rs. 410.00 and has touched a high and low of Rs. 410.00 and Rs. 374.10 respectively. So far 2,52,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 437.00 on 05-Nov-2015 and a 52 week low of Rs. 295.50 on 18-Jan-2016.

Last one week high and low of the scrip stood at Rs. 410.00 and Rs. 374.10 respectively. The current market cap of the company is Rs. 39,004.59 crore.

The promoters holding in the company stood at 74.79%, while Institutions and Non-Institutions held 17.25% and 7.96% respectively.

The company has reported 82.83% fall in its net profit at Rs 109.0 crore for second quarter ended September 30, 2016 as compared to Rs 634.7 crore for the same quarter in the previous year. Total income of the company decreased by 40.49% at Rs 1202.2 crore for Q2FY17 as compared Rs 2020.1 crore for the corresponding quarter previous year. 

On the consolidated basis, the company has reported 28.93% fall in its net profit after taxes, Minority Interest & Share of Rs 337.6 crore for the quarter ended September 30, 2016 as compared to Rs 475.0 crore for the same quarter in the previous year. However, total income of the company increased by 0.51% at Rs 2427.1 crore for quarter under review as compared to Rs 2414.9 crore for the quarter ended September 30, 2015.  


Zydus Lifesciences Share Price

922.45 -1.25 (-0.14%)
11-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.90
Dr. Reddys Lab 1272.95
Cipla 1512.10
Zydus Lifesciences 922.45
Lupin 2080.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×